2022
Return on Investment of the COVID-19 Vaccination Campaign in New York City
Sah P, Vilches T, Moghadas S, Pandey A, Gondi S, Schneider E, Singer J, Chokshi D, Galvani A. Return on Investment of the COVID-19 Vaccination Campaign in New York City. JAMA Network Open 2022, 5: e2243127. PMID: 36409495, PMCID: PMC9679875, DOI: 10.1001/jamanetworkopen.2022.43127.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccination campaignVaccination campaignIntensive care unit admissionCare unit admissionEmergency department visitsIndirect costsDecision analytical modelEmergency medical servicesCOVID-19 deathsHealth care expendituresUnit admissionDepartment visitsFuture COVID-19 outbreaksNew York CityOutpatient visitsVaccine uptakeSevere outcomesVaccination programPotential yearsMAIN OUTCOMEVaccinationHealth outcomesProbable casesSocietal perspectiveCare expenditures
2019
Ebola vaccination in the Democratic Republic of the Congo
Wells CR, Pandey A, Parpia AS, Fitzpatrick MC, Meyers LA, Singer BH, Galvani AP. Ebola vaccination in the Democratic Republic of the Congo. Proceedings Of The National Academy Of Sciences Of The United States Of America 2019, 116: 10178-10183. PMID: 31036657, PMCID: PMC6525480, DOI: 10.1073/pnas.1817329116.Peer-Reviewed Original ResearchConceptsContacts of casesImpact of vaccinationFrontline healthcare workersEbola vaccinationEbola vaccineVaccination programHealthcare workersLong-range disseminationVaccination campaignCase confirmationEbola transmissionHigh-risk regionsEbola riskVaccinationFuture outbreaksRiskEarly implementationEbolaLevel of riskDemocratic RepublicGlobal spreadOutbreakVaccineInfectionDoses